SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES The (Inevitable and Acceptable) Consequences of Using Generic Patient- Reported Outcomes in Technology.

Slides:



Advertisements
Similar presentations
Measuring outcomes Emma Frew October Measuring outcomes Learning objectives By the end of the session students should be able to – Explain how different.
Advertisements

Protocol Development.
Implementing Evidence- Based Practice Training in a Scientist-Practitioner Program David DiLillo Director of Clinical Training University of Nebraska-Lincoln.
1 The Future of Quality of Life Assessment in Cost-Effectiveness Research Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy.
DEVELOPMENT OF A PREFERENCE-BASED, CONDITION SPECIFIC PATIENT REPORTED OUTCOME MEASURE FOR USE WITH VENOUS ULCERATION Simon Palfreyman 1, John E Brazier.
1 Does it make a difference for the patient? Survival & Quality of life  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and.
Is it time to ban PSA? In support of OFSA… Stirling Bryan, PhD.
Using a discrete choice experiment with duration to estimate values for health states on the QALY scale Nick Bansback Assistant Professor School of Population.
Critical Appraisal Dr Samira Alsenany Dr SA 2012 Dr Samira alsenany.
Utility Assessment HINF Medical Methodologies Session 4.
A METHODOLOGY FOR MEASURING THE COST- UTILITY OF EARLY CHILDHOOD DEVELOPMENTAL INTERVENTIONS Quality of improved life opportunities (QILO)
The Importance of Decision Analytic Modelling in Evaluating Health Care Interventions Mark Sculpher Professor of Health Economics Centre for Health Economics.
Valuing Health Daniel M. Hausman University of Wisconsin-Madison October 19, 2009.
Michael A. Echteld Evaluation of QOL Instruments for Palliative Care.
Critical Appraisal of an Article by Dr. I. Selvaraj B. SC. ,M. B. B. S
Environmental Health Sciences Assignment 1 Review of an Article on Determinants of Quality of Life for People with Asthma.
…patient reported outcome (PRO) measure for your clinical study Dr Keith Meadows, DHP Research & Consultancy Ltd.
Social and Behavioral Sciences Assignment 1 Health Behavior Impact on Health- Related Quality of Life (HRQOL): Article Review and Behavioral Science Intervention.
Social and Behavioral Sciences Assignment 2
From Evidence to EMS Practice: Building the National Model Eddy Lang, MD, CFPC (EM), CSPQ SMBD-Jewish General Hospital, McGill University Montreal, Canada.
Measuring and valuing health outcome Montarat Thavorncharoensap, Ph.D. 1: Faculty of Pharmacy, Mahidol University 2. HITAP, Thailand.
MAPPING THE DIABETES HEALTH PROFILE (DHP-18) ONTO THE EQ-5D AND SF-6D GENERIC PREFERENCE BASED MEASURES OF HEALTH Brendan Mulhern 1, Keith Meadows 2, Donna.
1 EQ-5D, HUI and SF-36 Of the shelf instruments…..
Introduction to Effectiveness, Patient Preferences and Utilities Patsi Sinnott, PT, PhD, MPH HERC Economics Course May 6, 2009.
1 Health Economics  Comparing different allocations  Should we spent our money on Wheel chairs Screening for cancer  Comparing costs  Comparing outcome.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 16: Economic Evaluation using Decision.
Overview of the EQ-5D Purpose and origins of the descriptive system.
RESEARCH A systematic quest for undiscovered truth A way of thinking
Some Approaches to Evaluation: A Focus on Outcomes Assoc Prof Jan Sansoni Australian Health Outcomes Collaboration Australian Health Services Research.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 11: Cost-utility analysis – Part 4.
Why use the EQ-5D? What are the alternatives?. What are the alternatives for Direct valuation? Other VAS Time Trade-Off Standard Gamble Willingness to.
GENERAL INTRODUCTION TO HEALTH MEASUREMENT (Note: I have added explanatory notes to many of the slides; to see these you will need to save the file and.
UK Renal Registry 2013 Annual Audit Meeting
Quality school library – how do we find out? Polona Vilar Department of LIS&BS, Faculty of Arts, University of Ljubljana, SLO Ivanka Stričević Department.
University of Minnesota Medical Technology Evaluation and Market Research Department of Healthcare Management Course: MILI/PUBH 6589 Spring Semester, 2013.
PATIENT REPORTED OUTCOMES Albert W. Wu, MD, MPH Joseph Finkelstein, MD, PhD, MA, CCRP ICTR Clinical Registry Workshop, 10 November 2010.
Introduction Patients with tumors affecting the spine have significant impairments in Quality of Life domains that include physical function, neural function,
Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.
1.3 Modeling process and outcomes Walter Sermeus, RN, PhD Catholic University Leuven Belgium Witten, Fri Session 1: 11:00-12:30 Session 2: 13:30-15:00.
Basic Economic Analysis David Epstein, Centre for Health Economics, York.
Evaluating the impact of health research: Revisiting the Canadian Institutes of Health Research Impact Assessment Framework Nicola Lauzon, Marc Turcotte.
Decision Analysis Dr M G Dawes Centre for Evidence Based Medicine.
Evidence-Based Medicine Presentation [Insert your name here] [Insert your designation here] [Insert your institutional affiliation here] Department of.
1 EQ-5D, HUI and SF-36 Of the shelf instruments…..
Patsi Sinnott, PT, PhD, MPH HERC Economics Course April 7, 2010 Introduction to Effectiveness, Patient Preferences and Utilities.
OLGA: A nice niche designed to meet your evolving needs Pennifer Erickson, Ph.D. Presented at the Spring meeting of the Special Library Association’s Pharmaceutical.
Evidence-Based Medicine: What does it really mean? Sports Medicine Rounds November 7, 2007.
Overview of Health-Related Quality of Life Measures May 22, 2014 (1:00 – 2:00 PDT) Kaiser Methods Webinar Series 1 Ron D.Hays, Ph.D.
Appraisal of Guidelines for Research & Evaluation Using the AGREE¹ Instrument CAN-IMPLEMENT Toolkit Version 1.0 April 2010 Modified from:
Hermann P. G. Schneider, Alastair H. MacLennan and David Feeny
EQ-5D and SF-36 Quality of Life Measures in Systemic Lupus Erythematosus: Comparisons with RA, Non-Inflammatory Disorders (NIRD), and Fibromyalgia (FM)
“Introduction to Patient Preference Methods used for QALYs” Presented by: Jan Busschbach, PhD, Chair Section Medical Psychology and Psychotherapy, Department.
1 Evaluation of Patient-Centered Medical Home (PCMH) Initiatives Meredith B. Rosenthal, PhD February 24, 2009.
Research article structure: Where can reporting guidelines help? Iveta Simera The EQUATOR Network workshop 10 October 2012, Freiburg, Germany.
Validity and utility of theoretical tools - does the systematic review process from clinical medicine have a use in conservation? Ioan Fazey & David Lindenmayer.
Health Policy and Management Assignment 2 State and Community Health Profiles Health Disparity Policy Brief.
Epidemiology Assignment 2
Defining and measuring organizational readiness for change
The contribution of PROMs to health care sustainability Mark Harrison Stirling Bryan Deborah Marshall Nick Bansback.
Patient-Reported Outcomes Measurement Group Elizabeth Gibbons Senior Research Officer
PROMs Pilot for Long-Term Conditions in Primary Care Ray Fitzpatrick Department of Public Health.
Person Centred Approach in Rehabilitation Goal Setting Julia Johnson Community MS Team Walkergate.
PROMs in reimbursement and real-world assessments of clinical interventions Stirling Bryan, PhD.
Margareta Kristenson, Anita Jernberger, Preben Bendtsen The Swedish Network for Health Promoting Hospitals Patient Orientation by means of Health Related.
School of Population and Public Health PROMs to support informed patient decision making Nick Bansback, PhD Assistant Professor School of Population and.
Table 1. Characteristics of generic HRQOL assessments in adult physical activity research Peter D. Hart et al. Systematic Review of Health-Related Quality.
‘PhysioDirect’ for patients with MSK problems ECONOMIC MODEL OVERVIEW.
New Zealand Child and Youth Profile
Measuring outcomes Emma Frew October 2012.
Presentation transcript:

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES The (Inevitable and Acceptable) Consequences of Using Generic Patient- Reported Outcomes in Technology Appraisals: Issues of Accessibility in Challenging Clinical Contexts CADTH Symposium April 14 th, 2015 David Whitehurst, PhD Faculty of Health Sciences, Simon Fraser University Centre for Clinical Epidemiology and Evaluation (C2E2) Fraser Health Authority International Collaboration On Repair Discoveries (ICORD)

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Overview Key issues - health-related quality of life - methodological rigour Challenging contexts - spinal cord injury - aphasia

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Overview Key issues - health-related quality of life - methodological rigour Challenging contexts - spinal cord injury - aphasia “I know that validity isn’t as important to you guys but in our world it’s everything.”

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Generic v Condition-Specific Week #10: Measuring Benefits for Economic Evaluation

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Generic v Condition-Specific (1) Condition-specific measures -narrow assessment of a dimension (or dimensions) of health for a particular condition -sensitive to the condition under investigation -unable to be used for cross-condition comparisons E.g., Asthma Quality of Life Questionnaire (AQLQ) Dermatology Life Quality Index (DLQI) Arthritis Impact Measurement Scale (AIMS) Dementia Quality of Life (DEMQOL) Week #10: Measuring Benefits for Economic Evaluation

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Generic v Condition-Specific (2) Generic measures -broader assessment of HRQoL -enables cross-condition comparisons -can be insensitive (being less sensitive is not surprising) E.g., Nottingham Health Profile (NHP) SF-36, SF-12 & SF-6D Quality of Wellbeing Scale (QWB) EQ-5D-3L & EQ-5D-5L Health Utilities Index (HUI) Week #10: Measuring Benefits for Economic Evaluation

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Generic v Condition-Specific (2) Generic measures -broader assessment of HRQoL -enables cross-condition comparisons -can be insensitive (being less sensitive is not surprising) ‘profile’ & ‘index’ measures E.g., Nottingham Health Profile (NHP) SF-36, SF-12 & SF-6D Quality of Wellbeing Scale (QWB) EQ-5D-3L & EQ-5D-5L Health Utilities Index (HUI)

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES SF-36 (profile) Source: (amended for presentation purposes)

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES EQ-5D-3L (index & profile)

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Q1... Q2... Q3... Q4... Q5... Q6... Descriptive componentValuation component Preference-Based Measures + SELF-REPORT QUESTIONNAIRE

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES The ‘Holy Grail’ – a Futile Pursuit EQ-5D history: complementarity -“The raison d'être of the EuroQol Instrument is to provide a simple “abstracting” device, for use alongside other more detailed measures of HRQoL, to serve as a basis for comparing health care outcomes using a basic “common core” of QoL characteristics which most people are known to value highly” Why abandon convention? -an inherent trade-off -how inappropriate is too inappropriate? Kind P, Brooks R, Rabin R, eds. EQ-5D Concepts and Methods: A Developmental History. Dordrecht, The Netherlands: Springer, 2005.

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Spinal Cord Injury & Secondary Complications: A Mixed-Methods Evaluation of Preference-Based Instruments Funding: Rick Hansen Institute Translational Research Program Team: David GT Whitehurst Marcel FS Dvorak Nicole Mittmann Vanessa K Noonan Nitya Suryaprakash Stirling Bryan

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES SF-36v2 (SF-6D) “... the walking one hundred yards. Well, I can wheel 100 hundred yards without thinking but I’m not going to put that on here, I’m going to put ‘no’ and they look at it and say oh! that’s a problem” (FG3). “When I saw walking, I just kind of took it as wheeling... I’ll just say wheeling instead, I don’t mind crossing that off and putting that” (FG2). Medical Outcomes Study 36-item Short Form Health Survey (version 2)

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES HUIHUI “I have a really good quality of life but the way I had to answer the questions didn’t give me an option really to express that.” (FG1). “Question nine, they’re beating around the bush about equipment but they’re not mentioning you’re unable to walk but you are able to get around.” (FG3) Health Utilities Index

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Trade-off: generic measurement vs. relevancy AQoL-8D was the most preferred instrument Allowed us to make an evidence-based judgement regarding survey content Whitehurst DGT, et al. Health and Quality of Life Outcomes 2014

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES AQoL-8D ‘Mobility’ item responses of individuals at the lowest level on the EQ-5D-5L ‘Mobility’ dimension (n = 261; 72%)

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Ranked scatter graph of health state values for AQoL-8D, EQ-5D-5L, HUI-3 and SF-6D

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES ‘walk’ or ‘walking’ no reference to ‘walking’

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Preference-based HRQoL in the context of aphasia Team:David GT Whitehurst Aura Kagan Nina Simmons-Mackie Rebecca Palmer Nicholas R Latimer Jeffrey S Hoch

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Aphasia & QALYs Systematic review - very broad inclusion criteria - six studies identified; no conceptual or empirical evidence for the use of any existing instrument - feasibility versus validity Whitehurst DGT, et al. Aphasiology 2014

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Aphasia & QALYs Systematic review - very broad inclusion criteria - six studies identified; no conceptual or empirical evidence for the use of any existing instrument - feasibility versus validity The ‘Arthur Brisbane’ approach - aphasia-specific? - brand new generic outcome? - convert an existing instrument? Whitehurst DGT, et al. Aphasiology 2014

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Aphasia & QALYs: Pilot #1 (Ontario)

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Aphasia & QALYs: Pilot #2 (Sheffield, England)

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Summary / Discussion Generic preference-based instruments are complementary measures Understandable air of skepticism Divergence from convention is not an appropriate first step

SFU SIMON FRASER UNIVERSITY FACULTY OF HEALTH SCIENCES Acknowledgements